{"id":"W4286297227","doi":"10.1200/jco.2022.40.16_suppl.2513","title":"A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Tolerability; Internal medicine; Clinical endpoint; Rash; Adverse effect; Pharmacodynamics; Phases of clinical research; Oncology; Head and neck squamous-cell carcinoma; Pharmacokinetics; Gastroenterology; Toxicity; Pharmacology; Surgery; Clinical trial; Head and neck cancer; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009521963,0.001412394,0.001658995,0.0004170012,0.00042462,0.0008923273,0.0006986274,0.001241526,0.003263437],"category_scores_gemma":[0.0005417784,0.0005305121,0.0008927746,0.0003799287,0.0008321338,0.0007662607,0.000338824,0.002930381,0.0009949034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001101146,"about_ca_system_score_gemma":0.001474729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00151804,"about_ca_topic_score_gemma":0.002595667,"domain_scores_codex":[0.9996914,0.0001168024,0.00001318805,0.00005771913,0.00003567705,0.00008528138],"domain_scores_gemma":[0.9995719,0.00005919996,0.00007248103,0.00002863998,0.00002578281,0.0002421686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7655747,0.08638,0.00431578,0.0005038544,0.0008767412,0.0003171024,0.000205935,0.002303929,0.07640861,0.0002525643,0.003133744,0.05972697],"study_design_scores_gemma":[0.5140886,0.4699164,0.007613792,0.00001617424,0.0002963537,0.00024854,0.0000474736,0.001434869,0.004529887,0.0001224726,0.001664343,0.00002104442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944715,0.001075191,0.0002921278,0.0003386299,0.0001166526,0.001760267,0.0005400627,0.00005790723,0.001347519],"genre_scores_gemma":[0.9920324,0.0009108466,0.001050491,0.0005187581,0.0001241798,0.001760745,0.001482366,0.00001865517,0.002101584],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003263437,"threshold_uncertainty_score":0.01091731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03620175007699712,"score_gpt":0.3715357756216839,"score_spread":0.3353340255446868,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}